STOCK TITAN

DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DiaMedica Therapeutics (Nasdaq: DMAC) will release its Q4 2020 financial results after market close on March 10, 2021. A live conference call to discuss these results and a business update is scheduled for March 11, 2021, at 7:00 AM CT. Interested listeners can access the call via phone or a simultaneous webcast, and a playback will be available for 12 months. The conference ID for the call is 9297319. For more information, visit www.diamedica.com.

Positive
  • None.
Negative
  • None.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its fourth quarter 2020 financial results will be released after the markets close on Wednesday, March 10th. DiaMedica will host a live conference call on Thursday, March 11th at 7:00 AM Central Time to discuss its business update and financial results.

Conference Call details:

Date:

Thursday, March 11, 2021

Time:

7:00 AM CT / 8:00 AM ET

Web access:

https://event.on24.com/wcc/r/2948450/3CC8FC74172F3DEDB9258000144DA5E4

Dial In:

(866) 393-4306 (domestic)

(734) 385-2616 (international)

Conference ID:

9297319

Interested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until March 18, 2021, by dialing (855) 859-2056 (US Toll Free), (404) 537-3406 (International), replay passcode 9297319.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, please visit www.diamedica.com.

FAQ

When will DiaMedica Therapeutics release its Q4 2020 financial results?

DiaMedica Therapeutics will release its Q4 2020 financial results after market close on March 10, 2021.

What time is the conference call for DiaMedica's Q4 2020 financial results?

The conference call is scheduled for March 11, 2021, at 7:00 AM CT.

How can I access DiaMedica's conference call?

You can access DiaMedica's conference call by dialing (866) 393-4306 for domestic calls or (734) 385-2616 for international calls, or by using the webcast link provided.

What is the conference ID for DiaMedica's upcoming call?

The conference ID for DiaMedica's call is 9297319.

Will there be a replay available for the conference call?

Yes, there will be a telephonic replay available until March 18, 2021, and the webcast will remain available for 12 months.

DiaMedica Therapeutics Inc.

NASDAQ:DMAC

DMAC Rankings

DMAC Latest News

DMAC Stock Data

194.56M
26.04M
26.23%
31.61%
0.41%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MINNEAPOLIS